Precision Biosciences (DTIL) EBITDA Margin Growth (1y) (2019 - 2026)
Precision Biosciences (DTIL) EBITDA Margin Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.03 Bn | 467.24 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 122.09 Bn | 114.84 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.99 Bn | 50.80 Bn | 1.41 Bn | 1,049.00 |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 1,997.00 |
| 10 | Precision Biosciences | 182.42 Mn | 154.13 Mn | - | 7.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.62 Mn |
| Dec 31, 2025 | 393,093.00 |
| Sep 30, 2025 | -15.53 Mn |
| Jun 30, 2025 | -12.16 Mn |
| Mar 31, 2025 | -7.62 Mn |
| Dec 31, 2024 | -368,279.00 |
| Sep 30, 2024 | -359,935.00 |
| Jun 30, 2024 | 6,420.00 |
| Mar 31, 2024 | 12,828.00 |
| Dec 31, 2023 | -9,731.00 |
| Sep 30, 2023 | 10,509.00 |
| Jun 30, 2023 | 75,785.00 |
| Mar 31, 2023 | 67,199.00 |
| Dec 31, 2022 | 37,042.00 |
| Sep 30, 2022 | -15,130.00 |
| Jun 30, 2022 | -80,510.00 |
| Mar 31, 2022 | -70,945.00 |
| Dec 31, 2021 | -21,925.00 |
| Sep 30, 2021 | 30,569.00 |
| Jun 30, 2021 | 307,485.00 |